AstraZeneca PLC AZN

AZN Company Overview

AstraZeneca PLC is a global biopharmaceutical company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company operates primarily within the pharmaceutical and biotechnology industries, with a strong emphasis on science-driven innovation. Its core therapeutic areas include oncology, cardiovascular, renal and metabolism (CVRM), respiratory and immunology, and vaccines and immune therapies. AstraZeneca’s revenues are primarily generated from patented specialty medicines and biologics sold to healthcare systems, hospitals, and pharmacies worldwide.

Founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group, AstraZeneca has evolved into one of the world’s largest research-based pharmaceutical companies. Over the past decade, the company has repositioned its portfolio toward high-growth, specialty care areas—particularly oncology and biologics—supported by significant investment in R&D and strategic acquisitions. Its differentiated positioning is driven by a robust late-stage pipeline, strong biologics capabilities, and a growing presence in precision medicine.